Mr. Joseph A. Williamson

As part of the transaction, Joseph A. Williamson will join the CCRx Board of Directors.

"We believe the recapitalization of CCRx by Thoma Cressey and NewSpring Capital will allow us to better compete for today's long-term care customers as we continue to strive to provide the absolute best pharmacy services in the face of continuing pricing pressure," said Trite."I have found our partnership with Thoma Cressey to be invaluable and instrumental in moving to the next level, and now with the addition of New Spring Capital and Mr. Williamson's experience and expertise in long-term care, we will take CCRx to an even higher level," Trite added.

Joseph A. Williamson commented on the investment fundamentals stating, "This transaction has the key attributes that we seek in our investments: CCRx has a top-rate, proven management team led by Tom Trite; the institutional pharmacy business is large and growing along with the aging of America; and the Company has an expanding, loyal following of customers.